Psychiatric Journals
Psychiatry
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Psychiatry
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Psychiatry
        Anxiety
        Child/Adolescent Psych
        Eating Disorders
        Economics of Medicine
        Geriatric Psych
        Mood Disorders
        Neuro/Psych Pharmacol
        Neuropsych Sciences
        Other Psychiatry
        Pain Management
        Personality Disorders
        Popular Press
        Psychotherapy/analysis
        Schizophrenia/Psychosis
        Substance Abuse
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
post partum depression  post partum depression
ssri  ssri
pervasive developmental  pervasive developmental
adhd  adhd
alzheimer's  alzheimer's
nervosa  nervosa
ptsd  ptsd
bipolar  bipolar
personality  personality
methamphetamine  methamphetamine
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics
Bobo WV et al. - Melperone did not significantly increase prolactin PRL levels in male patients. However, melperone and typical neuroleptics caused increase in PRL levels in females. Further study of melperone's effects on PRL concentration is warranted.

Methods
  • Analysis of pre- and post-treatment PRL levels collected prospectively per protocol in a non-randomized study of 26 melperone-, 76 clozapine-, and 66 neuroleptic-treated patients with schizophrenia or schizoaffective disorder.
  • Cross-sectional analysis of a larger sample of patients with PRL data was also performed.

Results
  • For males, post-treatment PRL levels were significantly higher in the typical neuroleptic group compared with the melperone (p = 0.0001) and clozapine (p = 0.0001) groups, with no significant difference between clozapine and melperone.
  • For females, post-treatment PRL levels were significantly higher in the melperone group as compared to the clozapine group (p = 0.004).
  • There were too few typical neuroleptic-treated females to permit analysis of this sample.
  • However, the cross-sectional analysis of PRL data confirmed the results for melperone- and clozapine-treated females, and showed higher PRL levels in typical neuroleptic-treated females as compared with those who received melperone and clozapine.
[more...]
Sponsor

Read a Different Specialty

Psychiatric News
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Psychiatric News Profession Index

Psychiatric News
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.